BNET Industries
Market Cap:$142.2B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Sanofi-Aventis on hunt for Boston partners
-
Pfizer says in partnership deal with BMP in China
-
Pfizer Inc. PFE Says in Partnership Deal with BMP Sunstone in China
-
Pfizer Will Close R&D Sites, Cut Jobs
-
Status Of Pfizer And Wyeth Research Facilities
-
Monsanto MON Agrees to Acquire Pfizer's PFE Chesterfield Village Research Center for $435M
-
Pfizer slashing 600 jobs from its St. Louis area work force [St. Louis Post-Dispatch]
-
UPDATE: Abbott Labs: US Justice Department Probing Depakote
-
Trubion loses $6.2 million in Q3
-
BRIEF: Pfizer, Ligand ink JAK-3 pact
-
Generics Makers Line Up To Sell Copies Of Pfizer's Lipitor
-
ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment...
-
xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 4, 2009 : FLML, XING, AFFY and MOCO
-
Pfizer unveils its new Poultry Health division
-
Pfizer reportedly considers buying Protalix
-
Pfizer, GSK launch HIV drug company
-
Pfizer eyes deal with Israel's Protalix-newspaper
-
Report: Pfizer may make a bid for Protalix
-
Wockhardt says no plans to divest biotech biz
News & Analysis
Filter by
pfizer inc. - All News and Analysis
Pfizer's Chemistry Head Count: Lower than Before the Wyeth Merger
Seeking Alpha
- 2009-11-11
Derek Lowe submits: A reader who's unfortunately in a position to know the details sends along some numbers on Pfizer's PFE chemistry shakeout. According to his figures, Pfizer (pre-Wyeth merger) had about 900 chemists. The Wyeth deal brought in about 350, but no one expected the merged department to...
BMP Sunstone Partners with Pfizer to Distribute Endometriosis Treatment in China
Seeking Alpha
- 2009-11-11
ChinaBio Today submits: BMP Sunstone Corporation (NSDQ: BJGP) and Pfizer China (NYSE: PFE) have formed a strategic partnership to distribute and promote Depo-Provera (Medroxy-progesterone Acetate), a Pfizer product used to treat endometriosis, in China. Endometriosis is a medical condition in women of childbearing age that can cause significant pain....
Pfizer's New Look
Seeking Alpha
- 2009-11-10
Derek Lowe submits: The company has issued a press release detailing which sites are staying, and which are leaving: Pfizer PFE will have five main research sites that will serve as central hubs for research activities in BioTherapeutics, PharmaTherapeutics and Vaccines. These sites are: Cambridge, Mass.;...
Pfizer's R&D Cuts Render Kelo v. New London Eminent Domain Case a Waste of Time
BNET
- 2009-11-10
Pfizer PFE will close its New London, Conn., site and consolidate operations there at the nearby Groton, Conn., site in a swathe of R&D closures as the company seeks 19,500 job cuts in the wake of its merger with Wyeth. Pfizer's abandonment of its plans for New London render moot...
Another Look at Pfizer's Recent Moves
Seeking Alpha
- 2009-11-10
Derek Lowe submits: Pharmaconduct.org has another look at Pfizer's PFE announcement Monday, and tries to address some of the many unanswered questions left open by the company's press release. One thing that struck me and many others is that the company talked about "moving a number of functions" from...
Pfizer's Cutbacks Reflect Difficulties Facing Big Pharma
Seeking Alpha
- 2009-11-10
ChinaBio Today submits: Pfizer (NYSE: PFE) announced it would close six out of its 20 R&D facilities around the globe as part of its post-Wyeth-acquisition consolidation. Some employees will be transferred to other facilities, while others will be let go. Pfizer did not disclose how many of its R&D...
Pfizer's New Layout
BNET
- 2009-11-09
The company has issued a press release detailed which sites are staying, and which are leaving: . . .As part of the consolidation of research sites, Pfizer will significantly reduce R&D activities at some of its sites. The company will move a number of functions from Collegeville, Pa.; Pearl River,...
Pfizer Will Close Some R&D Sites, Cut Jobs
BNET
- 2009-11-09
This isn't surprising. Now that its acquistion of Wyeth is complete, the big drugmaker will "significantly reduce" R&D in various locations, and an undisclosed number of jobs will be gone (here's the press release). Various functions will be moved from Collegeville, Pa; Pearl River, NY; and St. Louis to other...
Law & Order: The Pfizer Episode! "Doped" Sketches the Kopchinski-Bextra Settlement
BNET
- 2009-11-09
Chung-chung! NBC on Friday night aired an episode of Law & Order that appears to have been inspired in part by Pfizer's $2.3 billion Bextra settlement. I'm not the only one who noticed the "ripped from the headlines" quality of "Doped," the eighth episode of season 20. CafePharma is already...
Pfizer Aiming for 30,900 Layoffs Through 2012
BNET
- 2009-11-06
Pfizer has laid off 26,300 employees since 2005, and hopes eventually to lay off a total of 30,900 through 2012, according to its 10-Q filing with the SEC. The company had several rounds of layoffs before its acquisition of Wyeth in an attempt to get $6 billion in annual savings...
Those who viewed this also viewed...
Industry Transcripts by Seeking Alpha
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
-
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ARNA
-
Javelin Pharmaceuticals, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about JAV
-
Alexza Pharmaceuticals, Inc., Q3 2009 Earnings Call Transcript
on Nov 09, 2009about ALXA
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
